159 related articles for article (PubMed ID: 36077809)
1. A Novel Artificial Intelligence-Based Approach for Quantitative Assessment of Angiogenesis in the Ex Ovo CAM Model.
Faihs L; Firouz B; Slezak P; Slezak C; Weißensteiner M; Ebner T; Ghaffari Tabrizi-Wizsy N; Schicho K; Dungel P
Cancers (Basel); 2022 Sep; 14(17):. PubMed ID: 36077809
[TBL] [Abstract][Full Text] [Related]
2. Deep Learning-Based Image Analysis for the Quantification of Tumor-Induced Angiogenesis in the 3D In Vivo Tumor Model-Establishment and Addition to Laser Speckle Contrast Imaging (LSCI).
Kuri PM; Pion E; Mahl L; Kainz P; Schwarz S; Brochhausen C; Aung T; Haerteis S
Cells; 2022 Jul; 11(15):. PubMed ID: 35954165
[TBL] [Abstract][Full Text] [Related]
3. Chick ex ovo culture and ex ovo CAM assay: how it really works.
Dohle DS; Pasa SD; Gustmann S; Laub M; Wissler JH; Jennissen HP; Dünker N
J Vis Exp; 2009 Nov; (33):. PubMed ID: 19949373
[TBL] [Abstract][Full Text] [Related]
4. IKOSA
Annese T; Tamma R; Ribatti D
Methods Mol Biol; 2023; 2572():129-139. PubMed ID: 36161413
[TBL] [Abstract][Full Text] [Related]
5. Chorioallantoic Membrane Assay as Model for Angiogenesis in Tissue Engineering: Focus on Stem Cells.
Merckx G; Tay H; Lo Monaco M; van Zandvoort M; De Spiegelaere W; Lambrichts I; Bronckaers A
Tissue Eng Part B Rev; 2020 Dec; 26(6):519-539. PubMed ID: 32220219
[TBL] [Abstract][Full Text] [Related]
6. A Cost-Effective and Efficient Chick Ex-Ovo CAM Assay Protocol to Assess Angiogenesis.
Naik M; Brahma P; Dixit M
Methods Protoc; 2018 May; 1(2):. PubMed ID: 31164562
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.
As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP
Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736
[TBL] [Abstract][Full Text] [Related]
8. Depletion of Embryonic Macrophages Leads to a Reduction in Angiogenesis in the Ex Ovo Chick Chorioallantoic Membrane Assay.
Tay H; Du Cheyne C; Demeyere K; De Craene J; De Bels L; Meyer E; Zijlstra A; Spiegelaere W
Cells; 2020 Dec; 10(1):. PubMed ID: 33375076
[TBL] [Abstract][Full Text] [Related]
9. Laser speckle contrast analysis (LASCA) technology for the semiquantitative measurement of angiogenesis in in-ovo-tumor-model.
Pion E; Asam C; Feder AL; Felthaus O; Heidekrueger PI; Prantl L; Haerteis S; Aung T
Microvasc Res; 2021 Jan; 133():104072. PubMed ID: 32949573
[TBL] [Abstract][Full Text] [Related]
10. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
11. Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.
Kennedy DC; Coen B; Wheatley AM; McCullagh KJA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008876
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of vascular colonisation and angio-conduction in porous silicon-substituted hydroxyapatite with various pore shapes in a chick chorioallantoic membrane (CAM) model.
Magnaudeix A; Usseglio J; Lasgorceix M; Lalloue F; Damia C; Brie J; Pascaud-Mathieu P; Champion E
Acta Biomater; 2016 Jul; 38():179-89. PubMed ID: 27131570
[TBL] [Abstract][Full Text] [Related]
13. Using
Mangir N; Dikici S; Claeyssens F; MacNeil S
ACS Biomater Sci Eng; 2019 Jul; 5(7):3190-3200. PubMed ID: 33405582
[TBL] [Abstract][Full Text] [Related]
14. Chick chorioallantoic membrane model to investigate role of migrasome in angiogenensis.
Zhang C; He H; Yin S; Gao M; Yu L
Biophys Rep; 2023 Oct; 9(5):241-254. PubMed ID: 38516298
[TBL] [Abstract][Full Text] [Related]
15. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents.
Tufan AC; Satiroglu-Tufan NL
Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046
[TBL] [Abstract][Full Text] [Related]
16. The Chick Embryo Chorioallantoic Membrane Model: A Research Approach for Ex Vivo and In Vivo Experiments.
Fraguas-Sánchez AI; Martín-Sabroso C; Torres-Suárez AI
Curr Med Chem; 2022; 29(10):1702-1717. PubMed ID: 34176455
[TBL] [Abstract][Full Text] [Related]
17. Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.
Nowak-Sliwinska P; Ballini JP; Wagnières G; van den Bergh H
Microvasc Res; 2010 Jan; 79(1):21-8. PubMed ID: 19857502
[TBL] [Abstract][Full Text] [Related]
18. A novel 3-d model of chick chorioallantoic membrane for ameliorated studies in angiogenesis.
Ejaz S; Chekarova I; Ashraf M; Lim CW
Cancer Invest; 2006 Oct; 24(6):567-75. PubMed ID: 16982460
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a chick embryo chorioallantoic membrane (CAM) based platform for evaluation of vasoactive medications.
Chen L; Wang S; Feng Y; Yu J; Coudyzer W; Van Ongeval C; Geng L; Li Y; Ni Y
Microvasc Res; 2022 Jul; 142():104372. PubMed ID: 35483521
[TBL] [Abstract][Full Text] [Related]
20. Extending the Applicability of
Merlos Rodrigo MA; Casar B; Michalkova H; Jimenez Jimenez AM; Heger Z; Adam V
Front Oncol; 2021; 11():707366. PubMed ID: 34540673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
